This Week in PLOS Medicine: Genetic testing for antidepressants; Human rights & ethics reviews
Two new articles published this week in PLOS Medicine:
Testing whether genetic information could inform the selection of the best drug for patients with depression, Rudolf Uher and colleagues search for genetic variants that could predict clinically meaningful responses to two major groups of antidepressants.
Joseph Amon and colleagues discuss the challenges of conducting human rights research in settings where local research ethics committees may favor the interests of the state over the interests of research participants.
Remember you can comment on, annotate and rate any PLOS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.